Results 31 to 40 of about 6,141 (264)

Practical Short Signature Batch Verification [PDF]

open access: yes, 2009
In many applications, it is desirable to work with digital signatures that are short, and yet where many messages from different signers be verified very quickly. RSA signatures satisfy the latter condition, but are generally thousands of bits in length.
Pedersen, Michael Østergaard   +7 more
core   +1 more source

Forward-Secure Multi-User Aggregate Signatures Based on zk-SNARKs

open access: yesIEEE Access, 2021
As a solution to mitigate the key exposure problems in the digital signature, the forward security has been proposed. The forward security guarantees the integrity of the messages generated in the past despite leaks of a current time period secret key by
Jeonghyuk Lee, Jihye Kim, Hyunok Oh
doaj   +1 more source

Improving Bitcoin’s Post-Quantum Transaction Efficiency With a Novel Lattice-Based Aggregate Signature Scheme Based on CRYSTALS-Dilithium and a STARK Protocol

open access: yesIEEE Access, 2022
This paper proposes a novel lattice-based aggregate signature (LAS) scheme that brings post-quantum security to the Bitcoin system without sacrificing its transaction efficiency. Bitcoin currently employs Elliptic Curve Digital Signature Algorithm (ECDSA)
Yunjia Quan
doaj   +1 more source

Certicateless Aggregate Short Signature Scheme [PDF]

open access: yes, 2016
An aggregate signature scheme is the aggregation of multiple signatures into a single compact signature of short string that can convince to any arbitrary verifier participating in the scheme.
Jayaprakash Kar
core  

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Comments on “Certificateless Short Aggregate Signature Scheme for Mobile Devices”

open access: yesIEEE Access
In the above paper “Certificateless Short Aggregate Signature Scheme for Mobile Devices” a pairing-based certificateless aggregate signature (CLAS) scheme was proposed. Although the authors claim that their CLAS scheme is secure and provide
Je Hong Park, Bonwook Koo
doaj   +1 more source

Cup‐Like Nuclei Is a Hallmark of DUX4/ERG Acute Lymphoblastic Leukemia and Reveals Cytoplasmic Mitochondria Accumulation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Cup‐like nuclei are a distinctive morphological feature observed in certain cases of acute lymphoblastic leukemia (ALL). We provide evidence that they characterize DUX4/ERG ALL independently of IKZF1 deletion and reveal marked mitochondrial accumulation in this ALL subset.
Chloé Arfeuille   +9 more
wiley   +1 more source

Efficient Certificateless Aggregate Signature Scheme [PDF]

open access: yes, 2012
[[abstract]]In ubiquitous computing, data should be able to be accessed from any location, and the correctness of data becomes vital during the communication.
劉兆樑;Liu, Chao-Liang;蔡淵裕;Tsai, Yuan-Yu;詹啟祥;Chan, Chi-Shiang
core  

A Lattice-Based Aggregate Signature Based on Revocable Identity [PDF]

open access: yes, 2023
In the practical application of identity-based aggregated signature schemes, the problems of singer’s key loss and signer’s identity invalidation often occur.
Cheng H., Li F., Santaniello D., Cui Y.
core   +1 more source

Prevalence of 21 Physician‐Defined Severe Toxicities Following Childhood Acute Lymphoblastic Leukemia Treatment: Australian Retrospective Cohort Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall survival now surpassing 90% in developed countries. However, treatments are not without adverse effects. In this study, we apply the severe toxicity‐free survival (STFS) framework to determine the prevalence of 21 physician‐defined severe ...
Lane Collier   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy